<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="787">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04479982</url>
  </required_header>
  <id_info>
    <org_study_id>Microbial infection with covid</org_study_id>
    <nct_id>NCT04479982</nct_id>
  </id_info>
  <brief_title>Microbial Infection and AMR in Hospitalized Patients With Covid 19</brief_title>
  <official_title>Microbial Infections and Antimicrobial Resistance (AMR) Patterns Associated With Hospitalized Patients With 2019 Novel Coronavirus Disease (COVID 19)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To detect microbial infection and AMR associated with COVID 19 infection.

      To correlate risk factors of COVID 19 patients with microbial infections and their effects on
      disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most common type of infection among ICU patients was bacterial or fungal pneumonia;
      bloodstream and urinary tract infections were also noted. Organisms cultured from patients
      included pandrug-resistant Acinetobacter baumannii, Klebsiella pneumoniae
      carbapenemase-producing K. pneumoniae, extended-spectrum Î²-lactamase (ESBL)- producing K.
      pneumoniae, ESBL-producing Pseudomonas aeruginosa, Enterobacter cloacae, Serratia marcescens,
      Aspergillus fumigatus, Aspergillus flavus, Candida albicans, and Candida glabrata .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 24, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Microbial infections and antimicrobial resistance (AMR) patterns associated with hospitalized patients with 2019 novel coronavirus disease (COVID 19)</measure>
    <time_frame>baseline</time_frame>
    <description>The correlation between microbial infection and COVID 19 infection and their effect on prognosis and disease outcome.</description>
  </primary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients with covid 19
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Covid infection

        Exclusion Criteria:

          -  Patients without covid 19
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alshymaa Ali, PHD</last_name>
    <phone>01090581638</phone>
    <email>shimaafahim25@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut hopital</name>
      <address>
        <city>Assiut</city>
        <zip>6001</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>shimaa faheem, master</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>July 17, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>September 20, 2020</last_update_submitted>
  <last_update_submitted_qc>September 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>ALShymaa faheem solyman ali</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

